National Institute of Arthritis and Musculoskeletal and Skin Diseases; Notice of Closed Meetings, 5921 [2024-01813]
Download as PDF
<![CDATA[
Federal Register / Vol. 89, No. 20 / Tuesday, January 30, 2024 / Notices
Name of Committee: National Institute of
Allergy and Infectious Diseases Special
Emphasis Panel; HHS–NIH–CDC–SBIR PHS
2024–1 Phase I and Phase II: Adjuvant
Discovery and Down-Selection for Vaccines
against Infectious and Immune-Mediated
Diseases (Topic 130).
Date: February 23, 2024.
Time: 10:00 a.m. to 5:00 p.m.
Agenda: To review and evaluate contract
proposals.
Place: National Institute of Allergy and
Infectious Diseases, National Institutes of
Health, 5601 Fishers Lane, Room 3G31B,
Rockville, MD 20892 (Video Assisted
Meeting).
Contact Person: James T. Snyder, Ph.D.,
Scientific Review Officer, Scientific Review
Program, Division of Extramural Activities,
National Institute of Allergy and Infectious
Diseases, National Institutes of Health, 5601
Fishers Lane, Room 3G31B, Rockville, MD
20892, (240) 669–5060, james.snyder@
nih.gov.
(Catalogue of Federal Domestic Assistance
Program Nos. 93.855, Allergy, Immunology,
and Transplantation Research; 93.856,
Microbiology and Infectious Diseases
Research, National Institutes of Health, HHS)
Dated: January 24, 2024.
Lauren A. Fleck,
Program Analyst, Office of Federal Advisory
Committee Policy.
[FR Doc. 2024–01776 Filed 1–29–24; 8:45 am]
Place: National Institutes of Health, One
Democracy Plaza, 6701 Democracy
Boulevard, Bethesda, MD 20892, (Virtual
Meeting).
Contact Person: Sushmita Purkayastha,
Ph.D., Scientific Review Officer, Scientific
Review Branch, National Institute of Arthritis
and Musculoskeletal and Skin Diseases, 6701
Democracy Boulevard, Room 814, Bethesda,
MD 20817, sushmita.purkayastha@nih.gov.
Name of Committee: Arthritis and
Musculoskeletal and Skin Diseases Initial
Review Group; Arthritis and Musculoskeletal
and Skin Diseases Special Grants Study
Section.
Date: February 29–March 1, 2024.
Time: 9:30 a.m. to 6:00 p.m.
Agenda: To review and evaluate grant
applications.
Place: National Institutes of Health, One
Democracy Plaza, 6701 Democracy
Boulevard, Bethesda, MD 20892, (Virtual
Meeting).
Contact Person: Yasuko Furumoto, Ph.D.,
Scientific Review Officer, Scientific Review
Branch, National Institute of Arthritis and
Musculoskeletal and Skin Diseases, 6701
Democracy Boulevard, Room 820, Bethesda,
MD 30892, 301–827–7835,
yasuko.furumoto@nih.gov.
(Catalogue of Federal Domestic Assistance
Program Nos. 93.846, Arthritis,
Musculoskeletal and Skin Diseases Research,
National Institutes of Health, HHS)
Dated: January 25, 2024.
Miguelina Perez,
Program Analyst, Office of Federal Advisory
Committee Policy.
BILLING CODE 4140–01–P
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
[FR Doc. 2024–01813 Filed 1–29–24; 8:45 am]
BILLING CODE 4140–01–P
National Institutes of Health
National Institute of Arthritis and
Musculoskeletal and Skin Diseases;
Notice of Closed Meetings
DEPARTMENT OF HOMELAND
SECURITY
[Docket Number DHS–2023–0017]
khammond on DSKJM1Z7X2PROD with NOTICES
Pursuant to section 1009 of the
Federal Advisory Committee Act, as
amended, notice is hereby given of the
following meetings.
The meetings will be closed to the
public in accordance with the
provisions set forth in sections
552b(c)(4) and 552b(c)(6), Title 5 U.S.C.,
as amended. The grant applications and
the discussions could disclose
confidential trade secrets or commercial
property such as patentable material,
and personal information concerning
individuals associated with the grant
applications, the disclosure of which
would constitute a clearly unwarranted
invasion of personal privacy.
Name of Committee: Arthritis and
Musculoskeletal and Skin Diseases Initial
Review Group; Arthritis and Musculoskeletal
and Skin Diseases Clinical Trials Study
Section.
Date: February 22–23, 2024.
Time: 9:00 a.m. to 5:00 p.m.
Agenda: To review and evaluate grant
applications.
VerDate Sep<11>2014
17:23 Jan 29, 2024
Jkt 262001
Agency Information Collection
Activities: USSS Citizens Academy
Application, Electronic Form
Department of Homeland
Security (DHS).
ACTION: 30-Day notice and request for
comments.
AGENCY:
The Department of Homeland
Security will submit the following
Information Collection Request (ICR) to
the Office of Management and Budget
(OMB) for review and clearance in
accordance with the Paperwork
Reduction Act of 1995. DHS Previously
published this ICR in the Federal
Register on Friday, November 17, 2023
for a 60-day public comment period.
There was one comment received by
DHS. The purpose of this notice is to
allow additional 30-days for public
comments
DATES: Comments are encouraged and
will be accepted until February 29,
SUMMARY:
PO 00000
Frm 00067
Fmt 4703
Sfmt 4703
5921
2024. This process is conducted in
accordance with 5 CFR 1320.1.
ADDRESSES: You may submit comments,
identified by docket number Docket
#DHS–2023–0017, at:
Æ Federal eRulemaking Portal:
https://www.regulations.gov. Please
follow the instructions for submitting
comments.
Instructions: All submissions received
must include the agency name and
docket number Docket #DHS–2023–
0017. All comments received will be
posted without change to https://
www.regulations.gov, including any
personal information provided.
Docket: For access to the docket to
read background documents or
comments received, go to https://
www.regulations.gov.
The
Agency has initiated a Citizens
Academy to inform the public about its
mission, focused on participation from
local community leaders. The academy
will take place in local Agency field
offices. Prior to participating, applicants
will need to provide information as
their community leadership role and
provide PII so that a background
investigation can be conducted to check
for criminal history, open warrants, etc.
The application allows for the Agency
to gather the information necessary for
each applicant to determine if they are
eligible for participation. Authority to
collect the information sought on this
form is derived from Title 28 U.S.C.
599A, 28 CFR 0.130, and 18 U.S.C.
3056.
This will be a new collection of
information. The Agency has initiated a
Citizens Academy for local community
members, who will need to fill out an
application to express interest and to
provide PII for the Agency to initiate a
background investigation for the
applicants prior to participating in the
USSS Citizens Academy. The
information will be gathered by
electronic submission of the USSS
Citizens Academy Application to local
Agency Field Offices. Applicant
information will also be used to contact
any applicants placed on a wait list to
join future USSS Citizens Academies.
All information collected will be via
electronic submission. The applicant
will receive a PDF form via email to
complete and submit to the agency. All
respondents are individuals, not small
businesses/entities.
The collection will only occur one
time per year upon initial application to
the Agency requesting to participate in
the USSS Citizens Academy. There
would be no way to reduce the
frequency or else community members
SUPPLEMENTARY INFORMATION:
E:\FR\FM\30JAN1.SGM
30JAN1
]]>Agencies
[Federal Register Volume 89, Number 20 (Tuesday, January 30, 2024)]
[Notices]
[Page 5921]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: 2024-01813]
-----------------------------------------------------------------------
DEPARTMENT OF HEALTH AND HUMAN SERVICES
National Institutes of Health
National Institute of Arthritis and Musculoskeletal and Skin
Diseases; Notice of Closed Meetings
Pursuant to section 1009 of the Federal Advisory Committee Act, as
amended, notice is hereby given of the following meetings.
The meetings will be closed to the public in accordance with the
provisions set forth in sections 552b(c)(4) and 552b(c)(6), Title 5
U.S.C., as amended. The grant applications and the discussions could
disclose confidential trade secrets or commercial property such as
patentable material, and personal information concerning individuals
associated with the grant applications, the disclosure of which would
constitute a clearly unwarranted invasion of personal privacy.
Name of Committee: Arthritis and Musculoskeletal and Skin
Diseases Initial Review Group; Arthritis and Musculoskeletal and
Skin Diseases Clinical Trials Study Section.
Date: February 22-23, 2024.
Time: 9:00 a.m. to 5:00 p.m.
Agenda: To review and evaluate grant applications.
Place: National Institutes of Health, One Democracy Plaza, 6701
Democracy Boulevard, Bethesda, MD 20892, (Virtual Meeting).
Contact Person: Sushmita Purkayastha, Ph.D., Scientific Review
Officer, Scientific Review Branch, National Institute of Arthritis
and Musculoskeletal and Skin Diseases, 6701 Democracy Boulevard,
Room 814, Bethesda, MD 20817, [email protected].
Name of Committee: Arthritis and Musculoskeletal and Skin
Diseases Initial Review Group; Arthritis and Musculoskeletal and
Skin Diseases Special Grants Study Section.
Date: February 29-March 1, 2024.
Time: 9:30 a.m. to 6:00 p.m.
Agenda: To review and evaluate grant applications.
Place: National Institutes of Health, One Democracy Plaza, 6701
Democracy Boulevard, Bethesda, MD 20892, (Virtual Meeting).
Contact Person: Yasuko Furumoto, Ph.D., Scientific Review
Officer, Scientific Review Branch, National Institute of Arthritis
and Musculoskeletal and Skin Diseases, 6701 Democracy Boulevard,
Room 820, Bethesda, MD 30892, 301-827-7835, [email protected].
(Catalogue of Federal Domestic Assistance Program Nos. 93.846,
Arthritis, Musculoskeletal and Skin Diseases Research, National
Institutes of Health, HHS)
Dated: January 25, 2024.
Miguelina Perez,
Program Analyst, Office of Federal Advisory Committee Policy.
[FR Doc. 2024-01813 Filed 1-29-24; 8:45 am]
BILLING CODE 4140-01-P
